Ostenhellweg 50-52, 44135 Dortmund, Germany
sales@kombi-med.com

External Quality Assessment in Histopathology and IHC

External Quality Assessment in Histopathology and IHC

External quality assessment in histopathology and immunohistochemistry: from staining to diagnosis

External quality assessment (EQA) in histopathology and immunohistochemistry (IHC) is an independent evaluation of the quality of tissue preparations and the accuracy of morphological diagnosis. Proficiency testing programs cover the entire workflow, from tissue fixation and processing to IHC staining and interpretation of results. In the era of targeted cancer therapy, the quality of IHC testing determines the choice of treatment.

The Importance of EQA in Anatomic Pathology

Histopathology and IHC are the areas where the subjective component of diagnosis is greatest. The pathologist's morphological report determines the diagnosis, the disease stage and the treatment strategy. The quality of tissue preparations and the intensity and specificity of IHC reactions directly affect the accuracy of interpretation.

Why EQA is critical:

  • IHC determines the choice of therapy: HER2, PD-L1 and ER/PR status in breast cancer; the prescription of targeted drugs depends on the result
  • Pre-analytical variability: fixation time, fixative type and processing protocol all affect IHC quality
  • Interlaboratory differences: up to 20% discordance in HER2 status assessment between laboratories that do not participate in EQA
  • Subjective interpretation: morphological assessment depends on the pathologist's expertise
  • Regulatory requirements: GOST R ISO 15189-2024 (the Russian national adoption of ISO 15189), ASCO/CAP guidelines for HER2 and PD-L1

EQA Areas in Histopathology

Quality of Tissue Preparations

  • Fixation: assessment of fixation adequacy (10% neutral buffered formalin, 6–72 hours)
  • Tissue processing: quality of dehydration, clearing and paraffin infiltration
  • Microtomy: section thickness and absence of artifacts
  • H&E staining: intensity, contrast and preservation of detail
  • Special stains: PAS, Masson's trichrome, Congo red, Perls' iron stain

Immunohistochemistry

  • Diagnostic markers: cytokeratins (CK7, CK20, CK5/6), vimentin, CD45, S-100
  • Prognostic markers: Ki-67, p53, ER, PR
  • Predictive markers: HER2, PD-L1, ALK, ROS1, MSI/MMR
  • Hematopathology: CD3, CD20, CD30, CD10, BCL2, BCL6, MUM1

Morphological Interpretation

  • Consensus diagnosis: assessment of the accuracy of the histological report
  • Tumor grading: reproducibility of differentiation grade assessment
  • Surgical margin assessment: completeness of resection

International EQA Programs

ProviderProgramFrequencyFocus
NordiQCIHC modules (90+ antibodies)2–4×/yearIHC staining quality assessment. Reference provider
UK NEQAS ICC & ISHImmunocytochemistry & ISH6×/yearIHC, FISH, ISH: comprehensive assessment
CAPSurgical Pathology3×/yearMorphological diagnosis
CAPIHC (HER2, ER/PR, PD-L1)2–4×/yearPredictive markers
ESP (European Society of Pathology)EQA Pathology2×/yearMorphology, IHC
API (American Proficiency Institute)Cytology, Histology3×/yearCytology and histology
INSTAND e.V.Pathology2×/yearHistology, IHC

NordiQC: The Gold Standard of IHC Quality Control

NordiQC (Nordic Immunohistochemical Quality Control) is the recognized global leader in external quality assessment for IHC. Key features:

  • More than 90 antibodies in the assessment program
  • Detailed feedback: each slide is scored on a standardized scale (Optimal, Good, Borderline, Poor)
  • Protocol recommendations: specific optimization recommendations are provided after an unsatisfactory result
  • Database of optimal protocols: access to validated protocols for all major IHC platforms

Equipment Compatibility

EquipmentManufacturerTypeRecommended EQA
Ventana BenchMark ULTRARocheAutomated IHC stainerNordiQC, UK NEQAS, CAP IHC
Ventana BenchMark GXRocheMid-range IHC stainerNordiQC, UK NEQAS
BOND-MAX / BOND RXLeicaAutomated IHC stainerNordiQC, UK NEQAS, CAP IHC
Autostainer Link 48Dako/AgilentIHC stainerNordiQC, UK NEQAS
Tissue-Tek PrismaSakuraAutomated H&E stainerCAP Histology, ESP
ST5020LeicaMultistainerCAP, ESP, INSTAND

IHC Quality Assessment Criteria

The NordiQC Scale

ScoreDescriptionAction
OptimalCorrect intensity, specificity and background stainingProtocol is optimal; continue
GoodMinor deviations, clinically acceptableConsider optimization
BorderlineRisk of misinterpretationProtocol optimization required
PoorUnacceptable qualityStop using the protocol immediately; take corrective action

What Is Assessed

  • Sensitivity: detection of true-positive cells
  • Specificity: absence of false-positive staining
  • Background staining: clean background with no artifacts
  • Controls: presence and adequacy of positive and negative controls
  • Intensity: consistency with the expected staining pattern

Practical Recommendations

EQA Participation Strategy

1. Mandatory minimum: NordiQC for all IHC antibodies in use; this is the global standard

2. For oncology laboratories: add CAP IHC (HER2, ER/PR, PD-L1) and UK NEQAS ICC

3. For morphological diagnosis: CAP Surgical Pathology + ESP EQA

4. For histotechnology: staining quality control (H&E, special stains) through CAP or ESP

5. For continuing education: CAP educational programs (PIP, NGC, PAP Education, HistoQIP) with CME credit for pathologists and CE credit for staff

Working with NordiQC Results

  • After a "Borderline" or "Poor" score, switch immediately to the protocol recommended by NordiQC
  • Use the NordiQC database to select optimal antibody clones and dilutions
  • Keep an IHC validation log linked to EQA results

Pre-Analytics: The Foundation of Quality

  • Standardize fixation time: 6–72 hours in 10% neutral buffered formalin
  • Monitor warm ischemia time, from tissue removal to placement in fixative
  • Keep a log of pre-analytical parameters for each block

EQA Is a Chance to Learn: CAP Education and Competency Programs

Every EQA round is also a training case. The pathologist examines the slide like a patient case, submits a diagnosis and then sees the intended answer, the peer results and, in the educational programs, a discussion of each case. That turns external quality assessment into continuing education for the whole team: participate, learn and claim CME credit.

The College of American Pathologists (CAP) runs the broadest set of such programs in anatomic pathology, cytopathology, histotechnology and molecular pathology:

ProgramDisciplineWhat participants doCredit
Performance Improvement Program in Surgical Pathology (PIP)Surgical pathologyChallenging cases with clinical history on glass slides or whole slide images; the diagnosis is compared with the expert answerCME for pathologists
Virtual Biopsy Program and digital slide programs (FNA, dermatopathology, neuropathology)Surgical pathology, cytology, subspecialtiesWhole slide images in the CAP's online viewerCME; CE for the FNA program
Nongynecologic Cytopathology Education (NGC)CytopathologyGlass slides and online casesCME and CE
PAP EducationGynecologic cytopathologyGlass slidesCME and CE
HistoQIP (with the National Society for Histotechnology)HistotechnologyThe laboratory sends its own H&E, special-stain and IHC slides; an expert panel grades fixation, processing, microtomy, staining and coverslipping, with peer comparisonLab-specific evaluation
Navigating Multimodality Biomarker Assessment (NMBA)Molecular pathology, biomarkersOnline cases combining IHC, ISH and molecular resultsCME and CE
Competency Assessment HubAll laboratory staffOnline courses such as immunohistochemistry, special stains and specimen handling, plus competency recordsCE
Every EQA round is a chance to learn: examine the case, report the result, compare with reference and peers, discuss in the team, claim CME or CE credit
Every EQA round is a chance to learn: examine the case, report the result, compare with reference and peers, discuss in the team, claim CME or CE credit

What the Credit Is Worth

Cytotechnologists can apply credit from the CAP cytopathology programs toward the continuing-education requirements of their professional bodies, and Surveys participants can claim CE credit at no extra charge through a free CAP web account (CAP catalogue 2024).

Whether CME or CE credit counts toward a national licence or recertification is decided by each country's licensing body, so ask yours which credits it recognizes. For a laboratory preparing for accreditation, documented participation is also evidence of staff competency, which both ISO 15189 and the CAP checklists require. More: how CAP EQA trains the laboratory team and Accreditation – CAP LAP and ISO norms.

KombiMED's Comprehensive Approach

KombiMED supplies the full range of equipment for anatomic pathology laboratories, from tissue processors and microtomes to automated IHC stainers (Roche Ventana BenchMark ULTRA, Leica BOND) and staining systems (Sakura Tissue-Tek, Leica ST5020). We also arrange enrollment in international EQA programs for histology and IHC.

Our specialists can help you:

Request a consultation on external quality assessment for your pathology laboratory.

In more depth in our EQC guide: EQA programmes by discipline, how IHC results are graded, EQA providers compared and Accreditation – CAP LAP and ISO norms.

  • Select EQA programs for IHC, special stains and morphological diagnosis
  • Select CAP educational and competency programs for pathologists and histotechnologists, with CME and CE credit
  • Optimize IHC protocols based on NordiQC recommendations
  • Prepare your laboratory for GOST R ISO 15189-2024 accreditation for morphological testing

Frequently Asked Questions

Can pathologists earn CME credit through EQA?
Yes. The CAP's educational programs in anatomic pathology and cytopathology (for example the Performance Improvement Program in Surgical Pathology, Nongynecologic Cytopathology Education and PAP Education) carry CME credit for pathologists, and several also CE credit for laboratory staff. Whether the credit counts toward a national licence is decided by the licensing body.
Which EQA programs does a histopathology laboratory need?
NordiQC for every IHC antibody in use, CAP or UK NEQAS for predictive markers such as HER2, ER/PR and PD-L1, CAP Surgical Pathology or ESP for morphological diagnosis, and a histotechnology program such as HistoQIP for staining quality.
Does EQA count as competency assessment?
It is one piece of evidence. ISO 15189 and the CAP checklists require a documented, regular assessment of each staff member's competence; EQA and educational case results are common evidence, alongside direct observation and record review.

Planning a purchase in this area?

Tell us what your laboratory needs and we will send you a tailored offer.

Contact KombiMED